OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Five decades of clinical assessment of whole-sporozoite malaria vaccines
Helena Nunes‐Cabaço, Diana Moita, Miguel Prudêncio
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

mRNA vaccine against malaria tailored for liver-resident memory T cells
Mitch Ganley, Lauren E. Holz, Jordan J. Minnell, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1487-1498
Closed Access | Times Cited: 36

Host-parasite interactions during Plasmodium infection: Implications for immunotherapies
Pankaj Chandley, Ravikant Ranjan, Sudhir Kumar, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 24

The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
Olivia A.C. Lamers, Blandine Franke‐Fayard, Jan Pieter R. Koopman, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 20, pp. 1913-1923
Closed Access | Times Cited: 10

A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
Arif Jamal Siddiqui, Jyoti Bhardwaj, Juhi Saxena, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 792-792
Open Access | Times Cited: 18

Systemic inflammatory response syndrome triggered by blood-borne pathogens induces prolonged dendritic cell paralysis and immunosuppression
Mitra Ashayeripanah, Javier Vega‐Ramos, Daniel Fernandez‐Ruiz, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113754-113754
Open Access | Times Cited: 5

A Progress Report in Advancements of Heterocyclic Compounds as Novel Antimalarial Agents over the Last 5 Years
Sumit Tahlan, Sucheta Singh, Meenakshi Kaira, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117393-117393
Closed Access

Parasite and vector circadian clocks mediate efficient malaria transmission
Inês Bento, Brianna Parrington, Rushlenne Pascual, et al.
Nature Microbiology (2025)
Open Access

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
E. Adrianne Hammershaimb, Andrea A. Berry
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 49-52
Open Access | Times Cited: 10

Recent Advances in the Treatment of Malaria
Jawaher M. Alghamdi, Arwa A. Al-Qahtani, Fatimah S. Alhamlan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 3

Antimalarial Agents Derived from Metal‐Amodiaquine Complexes with Activity in Multiple Stages of the Plasmodium Life Cycle
Legna Colina‐Vegas, Mariana C. Borges Silva, Caroline de Souza Pereira, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 55
Closed Access | Times Cited: 5

Malaria Genomics, Vaccine Development, and Microbiome
Xin‐zhuan Su, Rachel V. Stadler, Fangzheng Xu, et al.
Pathogens (2023) Vol. 12, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 4

The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria
Diana Moita, Catarina Rôla, Helena Nunes‐Cabaço, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4

A new malaria vaccination tool based on replication-competent Plasmodium falciparum parasites
Diana Moita, Miguel Prudêncio
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 667-669
Open Access | Times Cited: 1

Beyond RTS,S malaria vaccine piloting to adoption and historic introduction in sub-Saharan Africa: a new hope in the fight against the vector-borne disease
Adriano Focus Lubanga, Akim Nelson Bwanali, Chitemwa Moyo, et al.
Frontiers in Tropical Diseases (2024) Vol. 5
Open Access | Times Cited: 1

Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines
Diana Moita, Helena Nunes‐Cabaço, Catarina Rôla, et al.
Vaccine (2023) Vol. 41, Iss. 51, pp. 7618-7625
Open Access | Times Cited: 3

Babesia microti alleviates disease manifestations caused by Plasmodium berghei ANKA in murine co-infection model of complicated malaria
Imran Zafar, Tomoyo Taniguchi, Hanadi B. Baghdadi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2

Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism
Nirianne Palacpac, Ken J. Ishii, Nobuko Arisue, et al.
Parasitology International (2023) Vol. 99, pp. 102845-102845
Open Access | Times Cited: 2

Circadian rhythms mediate malaria transmission potential
Inês Bento, Brianna Parrington, Rushlenne Pascual, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Whole-sporozoite malaria vaccines: where we are, where we are going
Diana Moita, Miguel Prudêncio
EMBO Molecular Medicine (2024) Vol. 16, Iss. 10, pp. 2279-2289
Open Access

Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites
Mary Lopez-Perez, Aarti Jain, D. Huw Davies, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Pathogenesis of Plasmodium falciparum
R. E. Noor
(2024), pp. 19-40
Closed Access

A Plasmodium late liver stage arresting GAP provides superior protection in mice
Akancha Mishra, P. S. Paul, Mrigank Srivastava, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access

Page 1

Scroll to top